Actively Recruiting
Natural History of SMA: Long Term Longitudinal Study and Development of a Registry
Led by Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Updated on 2023-03-06
1200
Participants Needed
5
Research Sites
N/A
Total Duration
On this page
Sponsors
F
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Lead Sponsor
U
University of Milan
Collaborating Sponsor
AI-Summary
What this Trial Is About
This research aims to understand spinal muscular atrophy (SMA) by collecting and analyzing detailed information from a large group of patients over time. The study is observational and involves both looking back at past data and gathering new data from several academic centers in Italy. It focuses on how the disease progresses in patients who have and have not received treatment, and seeks to identify factors that affect disease progression. The study uses a structured disease registry shared among five academic centers to collect high-quality data on patients with SMA. Researchers gather information on motor function, respiratory health, nutrition, care levels, hospitalizations, and adverse events. Clinical evaluators and data managers are trained to ensure consistent and reliable data collection across all centers. Participants will be followed longitudinally, with data collected retrospectively and prospectively for up to 15 years. Researchers will assess motor function as the primary outcome, along with respiratory function and nutrition as secondary outcomes. The study also tracks patterns of care, hospitalizations, and adverse events to provide a comprehensive view of SMA over time.
CONDITIONS
Brief Title
Natural History of SMA
Who Can Participate
Eligibility Criteria
You may qualify if you...
- All patients with spinal muscular atrophy (SMA)
You will not qualify if you...
- Currently enrolled in other clinical trials
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - Up to 15 years
Participants with spinal muscular atrophy (SMA) are observed over time to understand the natural progression of the disease and collect information on functional measures, supportive care, hospitalizations, and adverse events.
Trial Site Locations
Total: 5 locations
1
Istituto Gaslini
Genova, Italy
Actively Recruiting
2
Nemo Sud
Messina, Italy
Actively Recruiting
3
Centro Clinico nemo
Milan, Italy
Actively Recruiting
4
Ospedale Bambino gesu
Rome, Italy
Actively Recruiting
5
Policlinico gemelli
Rome, Italy
Actively Recruiting
Research Team
E
Eugenio Mercuri, MD
M
Marika Pane, MD
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here